《半日速報》恆指半日收報23,252點 跌144點; 恆生科技指數半日收報5,615點 跌55點 阿裏巴巴跌逾3% 中國中藥、中集安瑞科、中國建築國際、中裕燃氣創新高
恆指半日收23,252點,跌144點或0.6%。恆生科技指數報5,615點,跌55點或1.0%。國指跌69點或0.8%,報8,166點。
活躍重磅股表現:
阿裏巴巴(09988.HK) 收114.4元,下跌3.8%;
友邦(01299.HK) 收79.3元,上升0.9%;
建行(00939.HK) 收5.44元,上升0.7%;
美團(03690.HK) 收223.8元,下跌0.7%;
騰訊(00700.HK) 收453.8元,下跌0.7%;
異動恆指及國指成份股:
融創中國(01918.HK) 收10.5元,下跌10.9%;
信達生物(01801.HK) 收44.3元,下跌8.2%;
申洲(02313.HK) 收138.1元,下跌7.9%;
藥明生物(02269.HK) 收86.85元,下跌6.2%;
京東健康(06618.HK) 收58元,下跌5.6%;
阿裏健康(00241.HK) 收6.23元,下跌5.5%;
碧桂園服務(06098.HK) 收44.15元,下跌5.5%;
華潤啤酒(00291.HK) 收61.65元,下跌3.4%;
碧桂園(02007.HK) 收6.69元,下跌3.3%;
安踏體育(02020.HK) 收113.2元,下跌3.2%;
海底撈(06862.HK) 收17.06元,下跌3.1%;
異動綜合中小型股:
華潤醫藥(03320.HK) 收4.28元,上升20.6%;
榮昌生物-B(09995.HK) 收66.2元,下跌15%;
中國中藥(00570.HK) 收5.85元,上升13.2%,創新高;
楓葉教育(01317.HK) 收0.61元,上升13%;
融創服務(01516.HK) 收6.94元,下跌12.7%;
首鋼資源(00639.HK) 收2.31元,下跌12.5%;
時代鄰裏(09928.HK) 收2.54元,下跌12.1%;
新城悅服務(01755.HK) 收9.98元,下跌10.7%;
諾輝健康(06606.HK) 收19.8元,下跌10.4%;
新東方在線(01797.HK) 收4.76元,下跌10%;
中集安瑞科(03899.HK) 收12.44元,上升9.7%,創新高;
中國建築國際(03311.HK) 收9.95元,上升2.7%,創新高;
中裕燃氣(03633.HK) 收8.38元,上升0.8%,創新高;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.